Table 1. Clinicopathological and surgical characteristics of patients with GC according to the groups.
| Variables | Control group n=535 (%) |
COVID group n=83 (%) |
p |
|---|---|---|---|
| Sex | 0.753 | ||
| Female | 203 (37.9) | 30 (36.1) | |
| Male | 332 (62.1) | 53 (63.9) | |
| Age (years) | 0.732 | ||
| Mean (SD) | 62.1 (12.9) | 61.7 (10.3) | |
| Body mass index (kg/m2) | 0.666 | ||
| Mean (SD) | 23.7 (4.7) | 23.9 (4.5) | |
| Hemoglobin (g/dL) | 0.773 | ||
| Mean (SD) | 11.6 (2.3) | 11.5 (2.7) | |
| Albumin (g/dL) | 0.985 | ||
| Mean (SD) | 3.8 (0.6) | 3.8 (0.7) | |
| Neutrophil-lymphocyte ratio (NLR) | 0.218 | ||
| Mean (SD) | 3.46 (3.97) | 4.26 (5.68) | |
| Charlson-Deyo Comorbidity Index (CCI) | 0.854 | ||
| 0 | 362 (67.7) | 57 (68.7) | |
| ≥1 | 173 (32.3) | 26 (31.3) | |
| ASA (American Society of Anesthesiologists) | 0.409 | ||
| I/II | 341 (63.7) | 49 (59) | |
| III/IV | 194 (36.3) | 34 (41) | |
| cTNM | 0.833 | ||
| I | 119 (22.2) | 15 (18.1) | |
| II | 81 (15.1) | 12 (14. 5) | |
| III | 163 (30.5) | 27 (32.5) | |
| IV | 172 (32.1) | 29 (34.9) | |
| Type of Surgery | 0.005 | ||
| Curative intent | 360 (67.3) | 46 (55.4) | |
| Diagnostic | 44 (8.2) | 16 (19.3) | |
| Palliative | 131 (24.5) | 21 (25.3) | |
| Lauren's type | 0.001 | ||
| Intestinal | 233 (43.6) | 25 (30.1) | |
| Diffuse/Mixed | 228 (42.6) | 37 (44.6) | |
| Not specified | 74 (13.8) | 21 (25.3) | |
| Preoperative chemotherapy | <0.001 | ||
| No | 435 (81.3) | 50 (60.2) | |
| Yes | 100 (18.7) | 33 (39.8) |
SD, standard deviation.